China Universal Asset Management Company’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Buy |
10,966
+342
| +3% | +$3.88K | 0.01% | 345 |
|
|
2025
Q1 | $70.7K | Sell |
10,624
-607
| -5% | -$4.04K | 0.01% | 389 |
|
|
2024
Q4 | $124K | Buy |
+11,231
| New | +$124K | 0.01% | 370 |
|
|
2023
Q4 | – | Sell |
-1,132
| Closed | -$4.46K | – | 478 |
|
|
2023
Q3 | $4.46K | Buy |
1,132
+553
| +96% | +$2.18K | ﹤0.01% | 398 |
|
|
2023
Q2 | $6.16K | Buy |
579
+44
| +8% | +$468 | ﹤0.01% | 352 |
|
|
2023
Q1 | $4.46K | Buy |
535
+134
| +33% | +$1.12K | ﹤0.01% | 377 |
|
|
2022
Q4 | $3.7K | Buy |
401
+32
| +9% | +$295 | ﹤0.01% | 333 |
|
|
2022
Q3 | $5K | Buy |
+369
| New | +$5K | ﹤0.01% | 277 |
|